Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bridge, MJ; Broadhead, KW; Hlady, V; Tresco, PA
   Ethanol treatment alters the ultrastructure and permeability of PAN-PVC hollow fiber cell encapsulation membranes
   JOURNAL OF MEMBRANE SCIENCE
   
   M.J. Bridge et al., "Ethanol treatment alters the ultrastructure and permeability of PAN-PVC hollow fiber cell encapsulation membranes", J MEMBR SCI, 195(1), 2002, pp. 51-64
2. Komatsu, H; Fujisawa, T; Sogo, T; Isozaki, A; Inui, A; Sekine, I; Kobata, M; Ogawa, Y
   Acute self-limiting hepatitis B after immunoprophylaxis failure in an infant
   JOURNAL OF MEDICAL VIROLOGY
   
   H. Komatsu et al., "Acute self-limiting hepatitis B after immunoprophylaxis failure in an infant", J MED VIROL, 66(1), 2002, pp. 28-33
3. Varani, S; Muratori, L; De Ruvo, N; Vivarelli, M; Lazzarotto, T; Gabrielli, L; Bianchi, FB; Bellusci, R; Landini, MP
   Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: Correlation with antigenemia
   JOURNAL OF MEDICAL VIROLOGY
   
   S. Varani et al., "Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: Correlation with antigenemia", J MED VIROL, 66(1), 2002, pp. 56-62
4. Bertolini, L; Iacovacci, S; Bosman, C; Carloni, G; Monaco, V; Bangrazi, C; Serafino, A; Gualandi, G; Prantera, G; Fruscalzo, A
   Low cell dosage of lymphoblastoid human cell lines EBV+ is associated to chronic hepatitis in a minority of inoculated nu/nu mice
   JOURNAL OF MEDICAL VIROLOGY
   
   L. Bertolini et al., "Low cell dosage of lymphoblastoid human cell lines EBV+ is associated to chronic hepatitis in a minority of inoculated nu/nu mice", J MED VIROL, 66(1), 2002, pp. 70-81
5. Yoshikawa, T; Ihira, M; Asano, Y; Tomitaka, A; Suzuki, K; Matsunaga, K; Kato, Y; Hiramitsu, S; Nagai, T; Tanaka, N; Kimura, H; Nishiyama, Y
   Fatal adult case of severe lymphocytopenia associated with reactivation ofhuman herpesvirus 6
   JOURNAL OF MEDICAL VIROLOGY
   
   T. Yoshikawa et al., "Fatal adult case of severe lymphocytopenia associated with reactivation ofhuman herpesvirus 6", J MED VIROL, 66(1), 2002, pp. 82-85
6. Holtappels, R; Thomas, D; Podlech, J; Reddehase, MJ
   Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2(d) haplotype
   JOURNAL OF VIROLOGY
   
   R. Holtappels et al., "Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2(d) haplotype", J VIROLOGY, 76(1), 2002, pp. 151-164
7. Nishikori, T; Ochi, M; Uchio, Y; Maniwa, S; Kataoka, H; Kawasaki, K; Katsube, K; Kuriwaka, M
   Effects of low-intensity pulsed ultrasound on proliferation and chondroitin sulfate synthesis of cultured chondrocytes embedded in Atelocollagen((R))gel
   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
   
   T. Nishikori et al., "Effects of low-intensity pulsed ultrasound on proliferation and chondroitin sulfate synthesis of cultured chondrocytes embedded in Atelocollagen((R))gel", J BIOMED MR, 59(2), 2002, pp. 201-206
8. Chang, SJ; Lee, CH; Hsu, CY; Wang, YJ
   Biocompatible microcapsules with enhanced mechanical strength
   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
   
   S.J. Chang et al., "Biocompatible microcapsules with enhanced mechanical strength", J BIOMED MR, 59(1), 2002, pp. 118-126
9. Harris, CE; Alcorn, SP
   To solve a deadly shortage: Economic incentives for human organ donation
   ISSUES IN LAW & MEDICINE
   
   C.E. Harris e S.P. Alcorn, "To solve a deadly shortage: Economic incentives for human organ donation", ISSUES LAW, 16(3), 2001, pp. 213-233
10. Melnik, K; Nakamura, M; Comella, K; Lasky, LC; Zborowski, M; Chalmers, JJ
    Evaluation of eluents from separations of CD34(+) cells from human cord blood using a commerical, immunomagnetic cell separation system
    BIOTECHNOLOGY PROGRESS
    
    K. Melnik et al., "Evaluation of eluents from separations of CD34(+) cells from human cord blood using a commerical, immunomagnetic cell separation system", BIOTECH PR, 17(5), 2001, pp. 907-916
11. Tamura, S; Kataoka, H; Matsui, Y; Shionoya, Y; Ohno, K; Michi, KI; Takahashi, K; Yamaguchi, A
    The effects of transplantation of osteoblastic cells with bone morphogenetic protein (BMP)/carrier complex on bone repair
    BONE
    
    S. Tamura et al., "The effects of transplantation of osteoblastic cells with bone morphogenetic protein (BMP)/carrier complex on bone repair", BONE, 29(2), 2001, pp. 169-175
12. Goodman, GR; Dissanayake, IR; Bowman, AR; Pun, S; Ma, Y; Jee, WSS; Bryer, HP; Epstein, S
    Transforming growth factor-beta administration modifies cyclosporine A-induced bone loss
    BONE
    
    G.R. Goodman et al., "Transforming growth factor-beta administration modifies cyclosporine A-induced bone loss", BONE, 28(6), 2001, pp. 583-588
13. Musgrave, DS; Pruchnic, R; Wright, V; Bosch, P; Ghivizzani, SC; Robbins, PD; Huard, J
    The effect of bone morphogenetic protein-2 expression on the early fate ofskeletal muscle-derived cells
    BONE
    
    D.S. Musgrave et al., "The effect of bone morphogenetic protein-2 expression on the early fate ofskeletal muscle-derived cells", BONE, 28(5), 2001, pp. 499-506
14. Willeke, F; Sturm, JW
    Minimal residual disease in soft-tissue sarcomas
    SEMINARS IN SURGICAL ONCOLOGY
    
    F. Willeke e J.W. Sturm, "Minimal residual disease in soft-tissue sarcomas", SEM SURG ON, 20(4), 2001, pp. 294-303
15. Nicolai, T
    Pediatric bronchoscopy
    PEDIATRIC PULMONOLOGY
    
    T. Nicolai, "Pediatric bronchoscopy", PEDIAT PULM, 31(2), 2001, pp. 150-164
16. Kok, LP
    Boon's disease: Hemorrhagic cystitis in conjunction with massive exfoliation of degenerated urothelial cells (apoptosis?) during intercontinental flights in an otherwise healthy person
    DIAGNOSTIC CYTOPATHOLOGY
    
    L.P. Kok, "Boon's disease: Hemorrhagic cystitis in conjunction with massive exfoliation of degenerated urothelial cells (apoptosis?) during intercontinental flights in an otherwise healthy person", DIAGN CYTOP, 25(6), 2001, pp. 361-364
17. Simsir, A; Oldach, D; Forest, G; Henry, M
    Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: Diagnosis by fine-needle aspiration biopsy
    DIAGNOSTIC CYTOPATHOLOGY
    
    A. Simsir et al., "Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: Diagnosis by fine-needle aspiration biopsy", DIAGN CYTOP, 24(2), 2001, pp. 129-131
18. Harada, H; Pavlick, KP; Hines, IN; Hoffman, JM; Bharwani, S; Gray, L; Wolf, RE; Grisham, MB
    Genome and hormones: Gender differences in physiology selected contribution: Effects of gender on reduced-size liver ischemia and reperfusion injury
    JOURNAL OF APPLIED PHYSIOLOGY
    
    H. Harada et al., "Genome and hormones: Gender differences in physiology selected contribution: Effects of gender on reduced-size liver ischemia and reperfusion injury", J APP PHYSL, 91(6), 2001, pp. 2816-2822
19. Wiesinger, GF; Quittan, M; Zimmermann, K; Nuhr, M; Wichlas, M; Bodingbauer, M; Asari, R; Berlakovich, G; Crevenna, R; Fialka-Moser, V; Peck-Radosavljevic, M
    Physical performance and health-related quality of life in men on a liver transplantation waiting list
    JOURNAL OF REHABILITATION MEDICINE
    
    G.F. Wiesinger et al., "Physical performance and health-related quality of life in men on a liver transplantation waiting list", J REHAB MED, 33(6), 2001, pp. 260-265
20. Quittan, M; Wiesinger, GF; Crevenna, R; Nuhr, MJ; Posch, M; Hulsmann, M; Muller, D; Pacher, R; Fialka-Moser, V
    Cross-cultural adaptation of the Minnesota living with heart failure questionnaire for German-speaking patients
    JOURNAL OF REHABILITATION MEDICINE
    
    M. Quittan et al., "Cross-cultural adaptation of the Minnesota living with heart failure questionnaire for German-speaking patients", J REHAB MED, 33(4), 2001, pp. 182-186
21. Walther, LE; Sens, A; Ebhardt, H; Gudziol, H
    Acute and fulminant fungal sinusitis in immunosuppressed patients.
    LARYNGO-RHINO-OTOLOGIE
    
    L.E. Walther et al., "Acute and fulminant fungal sinusitis in immunosuppressed patients.", LARY RH OTO, 80(7), 2001, pp. 394-399
22. Stennert, E; Jungehulsing, M
    Surgery of the salivary gland (including reconstructive facial surgery): Standard and quality assurance
    LARYNGO-RHINO-OTOLOGIE
    
    E. Stennert e M. Jungehulsing, "Surgery of the salivary gland (including reconstructive facial surgery): Standard and quality assurance", LARY RH OTO, 80, 2001, pp. S156-S197
23. Pohl, Y; Filippi, A; Kirschner, H
    Auto-alloplastic transplantation of a primary canine after traumatic loss of a permanent central incisor
    DENTAL TRAUMATOLOGY
    
    Y. Pohl et al., "Auto-alloplastic transplantation of a primary canine after traumatic loss of a permanent central incisor", DENT TRAUMA, 17(4), 2001, pp. 188-193
24. Filippi, A; Pohl, Y; von Arx, T
    Treatment of replacement resorption with Emdogain (R) - preliminary results after 10 months
    DENTAL TRAUMATOLOGY
    
    A. Filippi et al., "Treatment of replacement resorption with Emdogain (R) - preliminary results after 10 months", DENT TRAUMA, 17(3), 2001, pp. 134-138
25. Filippi, A; Pohl, Y; von Arx, T
    Decoronation of an ankylosed tooth for preservation of alveolar bone priorto implant placement
    DENTAL TRAUMATOLOGY
    
    A. Filippi et al., "Decoronation of an ankylosed tooth for preservation of alveolar bone priorto implant placement", DENT TRAUMA, 17(2), 2001, pp. 93-95
26. Efrat, J; Peretz, B
    Immediate repositioning of an accidentally extruded immature premolar after extracting root remnants of the primary molar
    DENTAL TRAUMATOLOGY
    
    J. Efrat e B. Peretz, "Immediate repositioning of an accidentally extruded immature premolar after extracting root remnants of the primary molar", DENT TRAUMA, 17(1), 2001, pp. 46-48
27. Andreone, P; Gramenzi, A; Cursaro, C; Biselli, M; Di Giammarino, L; Grazi, GL; Jovine, E; D'Errico, A; Galli, S; Mazziotti, A; Cavallari, A; Bernardi, M
    Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study
    DIGESTIVE AND LIVER DISEASE
    
    P. Andreone et al., "Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study", DIG LIVER D, 33(8), 2001, pp. 693-697
28. Romero-Gomez, M; Grande, L; Nogales, MC; Fernandez, M; Chavez, M; Castro, M
    Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption
    DIGESTIVE AND LIVER DISEASE
    
    M. Romero-Gomez et al., "Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption", DIG LIVER D, 33(8), 2001, pp. 698-702
29. Filipponi, F; Mosca, F
    Animal models of fulminant hepatic failure: need to test liver support devices
    DIGESTIVE AND LIVER DISEASE
    
    F. Filipponi e F. Mosca, "Animal models of fulminant hepatic failure: need to test liver support devices", DIG LIVER D, 33(7), 2001, pp. 607-613
30. De Filippi, F; Lampertico, P; Soffredini, R; Rumi, MG; Lunghi, G; Aroldi, A; Tarantino, A; Ponticelli, C; Colombo, M
    High prevalence, low pathogenicity of hepatitis G virus in kidney transplant recipients
    DIGESTIVE AND LIVER DISEASE
    
    F. De Filippi et al., "High prevalence, low pathogenicity of hepatitis G virus in kidney transplant recipients", DIG LIVER D, 33(6), 2001, pp. 477-479
31. Biancofiore, G; Valentini, C; Cellai, F; Filipponi, F; Mosca, F; Vagelli, A
    Report of a life-threatening arrhythmia after hospital discharge in a liver transplant recipient with previously unknown congenital long QT syndrome
    DIGESTIVE AND LIVER DISEASE
    
    G. Biancofiore et al., "Report of a life-threatening arrhythmia after hospital discharge in a liver transplant recipient with previously unknown congenital long QT syndrome", DIG LIVER D, 33(5), 2001, pp. 432-434
32. Torzilli, G
    Japanese approach to hepatocellular carcinoma
    DIGESTIVE AND LIVER DISEASE
    
    G. Torzilli, "Japanese approach to hepatocellular carcinoma", DIG LIVER D, 33(2), 2001, pp. 118-120
33. van As, AB; Lotz, Z; Tyler, M; Kahn, D
    Impact of Celsior solution on hepatocellular, reperfusion and endothelial cell injury after liver transplantation
    DIGESTIVE AND LIVER DISEASE
    
    A.B. van As et al., "Impact of Celsior solution on hepatocellular, reperfusion and endothelial cell injury after liver transplantation", DIG LIVER D, 33(2), 2001, pp. 181-186
34. Ino, K; Ageitos, AG; Singh, RK; Talmadge, JE
    Activation-induced T cell apoptosis by monocytes from stem cell products
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    K. Ino et al., "Activation-induced T cell apoptosis by monocytes from stem cell products", INT IMMUNO, 1(7), 2001, pp. 1307-1319
35. Mosca, M; Ruiz-Irastorza, G; Khamashta, MA; Hughes, GRV
    Treatment of systemic lupus erythematosus
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    M. Mosca et al., "Treatment of systemic lupus erythematosus", INT IMMUNO, 1(6), 2001, pp. 1065-1075
36. Bruserud, O
    Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    O. Bruserud, "Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia", INT IMMUNO, 1(12), 2001, pp. 2183-2195
37. Zajicova, A; Muckova, M; Krulova, M; Rychnavska, Z; Holan, V
    Immunosuppressive effects of vermiculine in vitro and in allotransplantation system in vivo
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    A. Zajicova et al., "Immunosuppressive effects of vermiculine in vitro and in allotransplantation system in vivo", INT IMMUNO, 1(11), 2001, pp. 1939-1945
38. Son, EH; Moon, EY; Rhee, DK; Pyo, S
    Stimulation of various functions in murine peritoneal macrophages by high mannuronic acid-containing alginate (HMA) exposure in vivo
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    E.H. Son et al., "Stimulation of various functions in murine peritoneal macrophages by high mannuronic acid-containing alginate (HMA) exposure in vivo", INT IMMUNO, 1(1), 2001, pp. 147-154
39. Huitema, ADR; Mathot, RAA; Tibben, MM; Rodenhuis, S; Beijnen, JH
    A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
    
    A.D.R. Huitema et al., "A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide", J PHARMA PH, 28(3), 2001, pp. 211-230
40. Alarcon-Segovia, D
    The future of treatment for systemic lupus erythematosus
    ISRAEL MEDICAL ASSOCIATION JOURNAL
    
    D. Alarcon-Segovia, "The future of treatment for systemic lupus erythematosus", ISR MED ASS, 3(2), 2001, pp. 127-130
41. Mor, E
    Current advances in liver support systems
    ISRAEL MEDICAL ASSOCIATION JOURNAL
    
    E. Mor, "Current advances in liver support systems", ISR MED ASS, 3(1), 2001, pp. 41-43
42. Sorkine, P; Ben Abraham, R; Brill, S; Szold, O
    Liver support systems
    ISRAEL MEDICAL ASSOCIATION JOURNAL
    
    P. Sorkine et al., "Liver support systems", ISR MED ASS, 3(1), 2001, pp. 44-49
43. Mawson, AR; Steele, TA
    Possible role of retinoids in hepatitis B virus-associated liver damage
    EXPERIMENTAL BIOLOGY AND MEDICINE
    
    A.R. Mawson e T.A. Steele, "Possible role of retinoids in hepatitis B virus-associated liver damage", EXP BIOL ME, 226(8), 2001, pp. 734-739
44. Katsuragi, I; Okeda, T; Yoshimatsu, H; Utsunomiya, N; Ina, K; Sakata, T
    Transplantation of normal islets into the portal vein of Otsuka Long EvansTokushima Fatty rats prevents diabetic progression
    EXPERIMENTAL BIOLOGY AND MEDICINE
    
    I. Katsuragi et al., "Transplantation of normal islets into the portal vein of Otsuka Long EvansTokushima Fatty rats prevents diabetic progression", EXP BIOL ME, 226(7), 2001, pp. 681-685
45. Kessels, HWHG; Wolkers, MC; van den Boom, MD; van der Valk, MA; Schumacher, TNM
    Immunotherapy through TCR gene transfer
    NATURE IMMUNOLOGY
    
    H.W.H.G. Kessels et al., "Immunotherapy through TCR gene transfer", NAT IMMUNOL, 2(10), 2001, pp. 957-961
46. Alyea, EP; Anderson, KC
    Allotransplantation for multiple myeloma
    CANCER JOURNAL
    
    E.P. Alyea e K.C. Anderson, "Allotransplantation for multiple myeloma", CANCER J, 7(3), 2001, pp. 166-174
47. Druker, BJ
    Current treatment approaches for chronic myelogenous leukemia
    CANCER JOURNAL
    
    B.J. Druker, "Current treatment approaches for chronic myelogenous leukemia", CANCER J, 7, 2001, pp. S14-S18
48. Anderson, KC
    Novel biologically based therapies for myeloma
    CANCER JOURNAL
    
    K.C. Anderson, "Novel biologically based therapies for myeloma", CANCER J, 7, 2001, pp. S19-S23
49. Psyrri, A; Murren, J
    Small cell lung cancer: Strategies to optimize chemotherapy response
    CANCER JOURNAL
    
    A. Psyrri e J. Murren, "Small cell lung cancer: Strategies to optimize chemotherapy response", CANCER J, 7, 2001, pp. S28-S34
50. Berenguer, M; Rayon, JM; Prieto, M; Aguilera, V; Nicolas, D; Ortiz, V; Carrasco, D; Lopez-Andujar, R; Mir, J; Berenguer, J
    Are posttransplantation protocol liver biopsies useful in the long term?
    LIVER TRANSPLANTATION
    
    M. Berenguer et al., "Are posttransplantation protocol liver biopsies useful in the long term?", LIVER TRANS, 7(9), 2001, pp. 790-796
51. Ong, J; Younossi, ZM; Reddy, V; Price, LL; Gramlich, T; Mayes, J; Boparai, N
    Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease
    LIVER TRANSPLANTATION
    
    J. Ong et al., "Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease", LIVER TRANS, 7(9), 2001, pp. 797-801
52. Genzone, A; Al-Shurafa, H; Mondello, R; Morelli, N; Antonucci, A; Valente, U; Andorno, E
    In situ splitting of a liver with middle hepatic vein anomaly
    LIVER TRANSPLANTATION
    
    A. Genzone et al., "In situ splitting of a liver with middle hepatic vein anomaly", LIVER TRANS, 7(9), 2001, pp. 826-828
53. Kneteman, NM
    Steroid-free immunosuppression: Balancing efficacy and toxicity
    LIVER TRANSPLANTATION
    
    N.M. Kneteman, "Steroid-free immunosuppression: Balancing efficacy and toxicity", LIVER TRANS, 7(8), 2001, pp. 698-700
54. Schiodt, FV; Ott, P; Tygstrup, N; Dahl, B; Bondesen, S
    Temporal profile of total, bound, and free Gc-globulin after acetaminophenoverdose
    LIVER TRANSPLANTATION
    
    F.V. Schiodt et al., "Temporal profile of total, bound, and free Gc-globulin after acetaminophenoverdose", LIVER TRANS, 7(8), 2001, pp. 732-738
55. Wiesner, RH; McDiarmid, SV; Kamath, PS; Edwards, EB; Malinchoc, M; Kremers, WK; Krom, RAF; Kim, WR
    MELD and PELD: Application of survival models to liver allocation
    LIVER TRANSPLANTATION
    
    R.H. Wiesner et al., "MELD and PELD: Application of survival models to liver allocation", LIVER TRANS, 7(7), 2001, pp. 567-580
56. Neuberger, J
    Recurrent primary biliary cirrhosis
    LIVER TRANSPLANTATION
    
    J. Neuberger, "Recurrent primary biliary cirrhosis", LIVER TRANS, 7(7), 2001, pp. 596-599
57. Ubel, PA; Jepson, C; Baron, J; Mohr, T; McMorrow, S; Asch, DA
    Allocation of transplantable organs: Do people want to punish patients forcausing their illness?
    LIVER TRANSPLANTATION
    
    P.A. Ubel et al., "Allocation of transplantable organs: Do people want to punish patients forcausing their illness?", LIVER TRANS, 7(7), 2001, pp. 600-607
58. Turnes, J; Garcia-Pagan, JC; Gonzalez-Abraldes, J; Real, M; Moitinho, E; Gilabert, R; Escorsell, A; Muntanya, X; Gines, P; Bosch, J; Rodes, J
    Stenosis of the suprahepatic inferior vena cava as a complication of transjugular intrahepatic portosystemic shunt in Budd-Chiari patients
    LIVER TRANSPLANTATION
    
    J. Turnes et al., "Stenosis of the suprahepatic inferior vena cava as a complication of transjugular intrahepatic portosystemic shunt in Budd-Chiari patients", LIVER TRANS, 7(7), 2001, pp. 649-651
59. Krowka, MJ
    Hepatopulmonary syndrome and extrahepatic vascular abnormalities
    LIVER TRANSPLANTATION
    
    M.J. Krowka, "Hepatopulmonary syndrome and extrahepatic vascular abnormalities", LIVER TRANS, 7(7), 2001, pp. 656-657
60. Neuhaus, P; Klupp, J; Langrehr, JM
    mTOR inhibitors: An overview
    LIVER TRANSPLANTATION
    
    P. Neuhaus et al., "mTOR inhibitors: An overview", LIVER TRANS, 7(6), 2001, pp. 473-484
61. Yu, AS; Vierling, JM; Colquhoun, SD; Arnaout, WS; Chan, CK; Khanafshar, E; Geller, SA; Nichols, WS; Fong, TL
    Transmission of hepatitis B infection from hepatitis B core antibody-positive liver allografts is prevented by lamivudine therapy
    LIVER TRANSPLANTATION
    
    A.S. Yu et al., "Transmission of hepatitis B infection from hepatitis B core antibody-positive liver allografts is prevented by lamivudine therapy", LIVER TRANS, 7(6), 2001, pp. 513-517
62. Rizzetto, M
    Transmission of hepatitis B infection from hepatitis B core antibody-positive livers: Background and prevention
    LIVER TRANSPLANTATION
    
    M. Rizzetto, "Transmission of hepatitis B infection from hepatitis B core antibody-positive livers: Background and prevention", LIVER TRANS, 7(6), 2001, pp. 518-520
63. Takeyama, O; Ikai, I; Yagi, T; Satoh, S; Kanazawa, A; Uesugi, T; Nishitai, R; Okabe, H; Katsura, N; Terajima, H; Yamaoka, Y
    Effects of prostaglandin E-1 on the efficacy of xenogeneic extracorporeal pig liver perfusion in a canine model of acute liver failure
    LIVER TRANSPLANTATION
    
    O. Takeyama et al., "Effects of prostaglandin E-1 on the efficacy of xenogeneic extracorporeal pig liver perfusion in a canine model of acute liver failure", LIVER TRANS, 7(6), 2001, pp. 526-532
64. Hurtova, M; Duclos-Vallee, JC; Johanet, C; Emile, JF; Roque-Afonso, AM; Feray, C; Bismuth, H; Samuel, D
    Successful tacrolimus therapy for a severe recurrence of type 1 autoimmunehepatitis in a liver graft recipient
    LIVER TRANSPLANTATION
    
    M. Hurtova et al., "Successful tacrolimus therapy for a severe recurrence of type 1 autoimmunehepatitis in a liver graft recipient", LIVER TRANS, 7(6), 2001, pp. 556-558
65. Kobashigawa, JA
    Statins as immunosuppressive agents - Statins as a newly recognized type of immunomodulator
    LIVER TRANSPLANTATION
    
    J.A. Kobashigawa, "Statins as immunosuppressive agents - Statins as a newly recognized type of immunomodulator", LIVER TRANS, 7(6), 2001, pp. 559-561
66. Rinella, ME; Alonso, E; Rao, S; Whitington, P; Fryer, J; Abecassis, M; Superina, R; Flamm, SL; Blei, AT
    Body mass index as a predictor of hepatic steatosis in living liver donors
    LIVER TRANSPLANTATION
    
    M.E. Rinella et al., "Body mass index as a predictor of hepatic steatosis in living liver donors", LIVER TRANS, 7(5), 2001, pp. 409-414
67. Trotter, JF
    Thin chance for fat people (To become living donors)
    LIVER TRANSPLANTATION
    
    J.F. Trotter, "Thin chance for fat people (To become living donors)", LIVER TRANS, 7(5), 2001, pp. 415-417
68. Gottschlich, MJ; Aardema, KL; Burd, EM; Nakhleh, RE; Brown, KA; Abouljoud, MS; Hirst, K; Moonka, DK
    The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C
    LIVER TRANSPLANTATION
    
    M.J. Gottschlich et al., "The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C", LIVER TRANS, 7(5), 2001, pp. 436-441
69. Baron, TH
    Establishing a systematic endoscopic approach to the management of anastomotic biliary strictures is needed
    LIVER TRANSPLANTATION
    
    T.H. Baron, "Establishing a systematic endoscopic approach to the management of anastomotic biliary strictures is needed", LIVER TRANS, 7(4), 2001, pp. 378-379
70. Bishop, GA; McCaughan, GW
    Immune activation is required for the induction of liver allograft tolerance: Implications for immunosuppressive therapy
    LIVER TRANSPLANTATION
    
    G.A. Bishop e G.W. McCaughan, "Immune activation is required for the induction of liver allograft tolerance: Implications for immunosuppressive therapy", LIVER TRANS, 7(3), 2001, pp. 161-172
71. Bravata, DM; Olkin, I; Barnato, AE; Keeffe, EB; Owens, DK
    Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: A systematic review
    LIVER TRANSPLANTATION
    
    D.M. Bravata et al., "Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: A systematic review", LIVER TRANS, 7(3), 2001, pp. 191-203
72. Pirenne, J; Aerts, R; Yoong, K; Gunson, B; Koshiba, T; Fourneau, I; Mayer, D; Buckels, J; Mirza, D; Roskams, T; Elias, E; Nevens, F; Fevery, J; McMaster, P
    Liver transplantation for polycystic liver disease
    LIVER TRANSPLANTATION
    
    J. Pirenne et al., "Liver transplantation for polycystic liver disease", LIVER TRANS, 7(3), 2001, pp. 238-245
73. Honore, P; Detry, O; Hamoir, E; Defechereux, T; Detroz, B; Meurisse, M; Jacquet, N
    Right hepatic lobectomy as a liver graft-saving procedure
    LIVER TRANSPLANTATION
    
    P. Honore et al., "Right hepatic lobectomy as a liver graft-saving procedure", LIVER TRANS, 7(3), 2001, pp. 269-273
74. Vargas, HE
    The real danger of lamivudine-resistant hepatitis B virus infection in theimmunocompromised host
    LIVER TRANSPLANTATION
    
    H.E. Vargas, "The real danger of lamivudine-resistant hepatitis B virus infection in theimmunocompromised host", LIVER TRANS, 7(3), 2001, pp. 279-281
75. Pastacaldi, S; Teixeira, R; Montalto, P; Rolles, K; Burroughs, AK
    Hepatic artery thrombosis after orthotopic liver transplantation: A reviewof nonsurgical causes
    LIVER TRANSPLANTATION
    
    S. Pastacaldi et al., "Hepatic artery thrombosis after orthotopic liver transplantation: A reviewof nonsurgical causes", LIVER TRANS, 7(2), 2001, pp. 75-81
76. Manzarbeitia, C; Reich, DJ; Rothstein, KD; Braitman, LE; Levin, S; Munoz, SJ
    Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients
    LIVER TRANSPLANTATION
    
    C. Manzarbeitia et al., "Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients", LIVER TRANS, 7(2), 2001, pp. 93-99
77. Deshpande, V; Burd, E; Aardema, KL; Ma, CK; Moonka, DK; Brown, KA; Abouljoud, MS; Nakhleh, RE
    High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome
    LIVER TRANSPLANTATION
    
    V. Deshpande et al., "High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome", LIVER TRANS, 7(2), 2001, pp. 118-124
78. Rajvanshi, P; McDonald, GB
    Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease
    LIVER TRANSPLANTATION
    
    P. Rajvanshi e G.B. McDonald, "Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease", LIVER TRANS, 7(2), 2001, pp. 154-157
79. McCashland, TM
    Posttransplantation care: Role of the primary care physician versus transplant center
    LIVER TRANSPLANTATION
    
    T.M. McCashland, "Posttransplantation care: Role of the primary care physician versus transplant center", LIVER TRANS, 7(11), 2001, pp. S2-S12
80. Levy, GA
    Long-term immunosuppression and drug interactions
    LIVER TRANSPLANTATION
    
    G.A. Levy, "Long-term immunosuppression and drug interactions", LIVER TRANS, 7(11), 2001, pp. S53-S59
81. Wiesner, RH; Menon, KVN
    Late hepatic allograft dysfunction
    LIVER TRANSPLANTATION
    
    R.H. Wiesner e K.V.N. Menon, "Late hepatic allograft dysfunction", LIVER TRANS, 7(11), 2001, pp. S60-S73
82. McDiarmid, SV
    Management of the pediatric liver transplant patient
    LIVER TRANSPLANTATION
    
    S.V. McDiarmid, "Management of the pediatric liver transplant patient", LIVER TRANS, 7(11), 2001, pp. S77-S86
83. Faust, TW
    Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation
    LIVER TRANSPLANTATION
    
    T.W. Faust, "Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation", LIVER TRANS, 7(11), 2001, pp. S99-S108
84. Archambault, AJ; Sirois, MG; Bernatchez, PN; Fiset, C; Haddad, PS
    Vascular endothelial growth factor production by isolated rat hepatocytes after cold ischemia-warm reoxygenation
    LIVER TRANSPLANTATION
    
    A.J. Archambault et al., "Vascular endothelial growth factor production by isolated rat hepatocytes after cold ischemia-warm reoxygenation", LIVER TRANS, 7(11), 2001, pp. 988-997
85. Singh, N
    Cytomegalovirus infection of liver transplant recipients: Comparison of antigenemia and molecular biology assays
    LIVER TRANSPLANTATION
    
    N. Singh, "Cytomegalovirus infection of liver transplant recipients: Comparison of antigenemia and molecular biology assays", LIVER TRANS, 7(11), 2001, pp. 1004-1007
86. Marcos, A; Orloff, M; Mieles, L; Olzinski, AT; Renz, JF; Sitzmann, JV
    Functional venous anatomy for right-lobe grafting and techniques to optimize outflow
    LIVER TRANSPLANTATION
    
    A. Marcos et al., "Functional venous anatomy for right-lobe grafting and techniques to optimize outflow", LIVER TRANS, 7(10), 2001, pp. 845-852
87. Ramcharan, T; Glessing, B; Lake, JR; Payne, WD; Humar, A
    Outcome of other organs recovered during in situ split-liver procurements
    LIVER TRANSPLANTATION
    
    T. Ramcharan et al., "Outcome of other organs recovered during in situ split-liver procurements", LIVER TRANS, 7(10), 2001, pp. 853-857
88. Alberti, AB; Belli, LS; Airoldi, A; de Carlis, L; Rondinara, G; Minola, E; Vangeli, M; Cernuschi, A; D'Amico, M; Forti, D; Pinzello, G
    Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study
    LIVER TRANSPLANTATION
    
    A.B. Alberti et al., "Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study", LIVER TRANS, 7(10), 2001, pp. 870-876
89. Starzl, TE
    The "privileged" liver and hepatic tolerogenicity
    LIVER TRANSPLANTATION
    
    T.E. Starzl, "The "privileged" liver and hepatic tolerogenicity", LIVER TRANS, 7(10), 2001, pp. 918-920
90. Platt, JL
    Xenotransplantation of the liver: Is more complement control needed?
    LIVER TRANSPLANTATION
    
    J.L. Platt, "Xenotransplantation of the liver: Is more complement control needed?", LIVER TRANS, 7(10), 2001, pp. 933-934
91. Romero, M; Garcia-Monzon, D; Clemente, G; Salcedo, M; Alvarez, E; Majano, PL; Moreno-Otero, R
    Intrahepatic expression of inducible nitric oxide synthase in acute liver allograft rejection: Evidence of modulation by corticosteroids
    LIVER TRANSPLANTATION
    
    M. Romero et al., "Intrahepatic expression of inducible nitric oxide synthase in acute liver allograft rejection: Evidence of modulation by corticosteroids", LIVER TRANS, 7(1), 2001, pp. 16-21
92. van As, AB; Lotz, Z; Tyler, M; Kahn, D
    Effect of early arterialization of the porcine liver allograft on reperfusion injury, hepatocellular injury, and endothelial cell dysfunction
    LIVER TRANSPLANTATION
    
    A.B. van As et al., "Effect of early arterialization of the porcine liver allograft on reperfusion injury, hepatocellular injury, and endothelial cell dysfunction", LIVER TRANS, 7(1), 2001, pp. 32-37
93. Yasutomi, M; Harmsmen, S; Innocenti, F; DeSouza, N; Krom, RAF
    Outcome of the use of pediatric donor livers in adult recipients
    LIVER TRANSPLANTATION
    
    M. Yasutomi et al., "Outcome of the use of pediatric donor livers in adult recipients", LIVER TRANS, 7(1), 2001, pp. 38-40
94. McDiarmid, S
    How can we optimize the outcome of liver grafts from pediatric donors?
    LIVER TRANSPLANTATION
    
    S. McDiarmid, "How can we optimize the outcome of liver grafts from pediatric donors?", LIVER TRANS, 7(1), 2001, pp. 48-50
95. Petrovic, LM
    Regenerating liver cells
    LIVER TRANSPLANTATION
    
    L.M. Petrovic, "Regenerating liver cells", LIVER TRANS, 7(1), 2001, pp. 70-72
96. Fisher, MD
    Update of the French studies of autologous transplantation in multiple myeloma
    CLINICAL LYMPHOMA
    
    M.D. Fisher, "Update of the French studies of autologous transplantation in multiple myeloma", CLIN LYMPHO, 2(2), 2001, pp. 80-83
97. Fisher, MD
    Recombinant immunotoxins in the treatment of Hodgkin's lymphoma
    CLINICAL LYMPHOMA
    
    M.D. Fisher, "Recombinant immunotoxins in the treatment of Hodgkin's lymphoma", CLIN LYMPHO, 2(2), 2001, pp. 84-85
98. Thompson, DR; Faust, TW; Stone, MJ; Polter, DE
    Hepatic failure as the presenting manifestation of malignant lymphoma
    CLINICAL LYMPHOMA
    
    D.R. Thompson et al., "Hepatic failure as the presenting manifestation of malignant lymphoma", CLIN LYMPHO, 2(2), 2001, pp. 123-128
99. Kyle, RA
    Management of patients with multiple myeloma: Emphasizing the role of high-dose therapy
    CLINICAL LYMPHOMA
    
    R.A. Kyle, "Management of patients with multiple myeloma: Emphasizing the role of high-dose therapy", CLIN LYMPHO, 2(1), 2001, pp. 21-28
100. Moog, R
     Adverse events in peripheral progenitor cell collection: A 7-year experience
     JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
     
     R. Moog, "Adverse events in peripheral progenitor cell collection: A 7-year experience", J HEMATH ST, 10(5), 2001, pp. 675-680